Literature DB >> 15541797

Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells.

Keigo Kurata1, Akira Iwata, Kenichi Masuda, Masahiro Sakaguchi, Koichi Ohno, Hajime Tsujimoto.   

Abstract

Oligodeoxynucleotides containing the cytosine-phosphate-guanine (CpG) motif (CpG-ODNs) have been shown to induce T(H)1 immune responses in animals. Since the sequences of CpG-ODNs that induce T(H)1 responses are considered to vary among animal species, it is necessary to identify effective CpG-ODNs in each animal. In order to identify the sequences of CpG-ODNs that induce T(H)1 responses in dogs, mRNA expression and protein production of IFN-gamma were examined in peripheral blood mononuclear cells (PBMCs) from healthy dogs treated with 11 kinds of synthetic CpG-ODNs. One of the 11 CpG-ODNs (No. 2 CpG-ODN, 5'-GGTGCATCGATGCAGGGGGG-3') was shown to significantly increase mRNA expression and protein production of IFN-gamma in canine PBMCs in a manner dependent on the sequence of the CpG motif. This CpG-ODN also enhanced the expression of IL-12 p40 mRNA in canine PBMCs, whereas expression of IL-12 p35, IL-18, and IL-4 mRNAs was not induced by this CpG-ODN. These results indicate that this CpG-ODN was able to produce IFN-gamma by induction of T(H)1-skewed immune response in dogs. CpG-ODNs may be useful for inducing prophylactic and therapeutic immunity against allergic diseases, viral infection, and tumors in dogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541797     DOI: 10.1016/j.vetimm.2004.08.004

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

1.  Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Antiviral Res       Date:  2019-06-25       Impact factor: 5.970

2.  Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.

Authors:  Weidong Xiong; Marianela Candolfi; Chunyan Liu; A K M Ghulam Muhammad; Kader Yagiz; Mariana Puntel; Peter F Moore; Julie Avalos; John D Young; Dorothy Khan; Randy Donelson; G Elizabeth Pluhar; John R Ohlfest; Kolja Wawrowsky; Pedro R Lowenstein; Maria G Castro
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

3.  Induction of a systemic antiviral state in vivo in the domestic cat with a class A CpG oligonucleotide.

Authors:  Céline Robert-Tissot; Marina L Meli; Barbara Riond; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2012-08-04       Impact factor: 2.046

4.  Characterization of MDCK cells and evaluation of their ability to respond to infectious and non-infectious stressors.

Authors:  Francesca Maria Capellini; Walter Vencia; Massimo Amadori; Giulia Mignone; Erica Parisi; Lucia Masiello; Barbara Vivaldi; Angelo Ferrari; Elisabetta Razzuoli
Journal:  Cytotechnology       Date:  2019-12-04       Impact factor: 2.058

5.  Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families.

Authors:  Céline Robert-Tissot; Vera L Rüegger; Valentino Cattori; Marina L Meli; Barbara Riond; Peter F Moore; Monika Engels; Marco Franchini; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Res       Date:  2012-08-20       Impact factor: 3.683

6.  Broad-spectrum drugs against viral agents.

Authors:  Mary E Christopher; Jonathan P Wong
Journal:  Int J Mol Sci       Date:  2008-09-01       Impact factor: 6.208

7.  Characterization of a surface glycoprotein from Echinococcus multilocularis and its mucosal vaccine potential in dogs.

Authors:  Hirokazu Kouguchi; Jun Matsumoto; Ryo Nakao; Kimiaki Yamano; Yuzaburo Oku; Kinpei Yagi
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

8.  Treatment with Class A CpG Oligodeoxynucleotides in Cats with Naturally Occurring Feline Parvovirus Infection: A Prospective Study.

Authors:  Filippo Ferri; Federico Porporato; Francesco Rossi; Daniela Enache; Carolina Callegari; Gabriele Gerardi; Luigi M Coppola; Barbara Contiero; Chiara Crinò; Neda Ranjbar Kohan; Marina L Meli; Hans Lutz; Regina Hofmann-Lehmann; Eric Zini
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.